Company / Cash per Share
CRESCENT BIOPHARMA, INC. Cash per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$209.30
FY2025
5-year range
$0.12 / $209.30
FY2021-FY2025
Trend
+12052.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share changed +12053% YoY in FY2025, a notable deviation from the 4-year average annual change of +3547%.
Based on SEC 10-K filings.
209.30 in FY2025 with a 10-year CAGR of +110.6%.
Improved from $2.90 to $209.30 over the past 9 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +110.6%
Key checks
Key Insights
- In FY2025, cash per share increased 12052.8% year-over-year.
- Lowest cash per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $209.30 | +12052.8% |
| FY2017 | $1.72 | -40.6% |
| FY2016 | $2.90 | +2275.1% |
| FY2015 | $0.12 | -99.0% |
| FY2014 | $12.18 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026